| Back-ground |
A biotechnology development organization was planning on investing resources to develop an advanced biologic product for the treatment of a rare disease. There was a clear, unmet medical need for better treatments for this condition and the proposed therapy would represent a major advancement.
|
|
|
| Challenges |
- The development timeline was projected to be 7+ years
- Market reports indicated >15 competitors with a wide range of probabilities and timing
- The project team did not have a structured assessment of the where their product fit into the competitive landscape
- The team had a myopic focus on forging ahead with a technology that may be obsolete before it was launched
|
|
|
| Solution |
ForeRunner Strategy led an analytical process to assess market data on competitive technologies. ForeRunner and the client team placed each compound on a competitive matrix and generated an objective assessment of the product’s potential for success.
|
|
|
| Result |
Product development funding was approved for the next phase. The team decided to consider advancing the 2nd and 3rd generation technologies to increase the probability of success. Close monitoring of the competitive intelligence data was recommended.
|
(267) 441-3254